Effectiveness of corticosteroid therapy in patients with moderate to severe coronavirus disease 2019: a retrospective study
Introduction: Ne An acute respiratory infection started in Wuhan city of China in December 2019. The pathogen was discovered as a novel coronavirus from the Coronaviridae family and called the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). According to clinical symptoms and laboratory...
Main Authors: | Sara Sadeghi, Marjan Mansourian, Sara Ebrahimi, Baran Kahid Basiri, Niloofar Nikgoftar, Soheila Jalali, Ramin Sami |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2023-06-01
|
Series: | Journal of Nephropharmacology |
Subjects: | |
Online Access: | https://jnephropharmacology.com/PDF/npj-12-e10577.pdf |
Similar Items
-
Methylprednisolone pulse therapy for critically ill patients with coronavirus disease 2019: A single‐center retrospective observational study
by: Hiromu Okano, et al.
Published: (2022-01-01) -
Nebulized corticosteroids in the management of acute exacerbation of COPD
by: Gaude G, et al.
Published: (2010-01-01) -
The Use of Intralesional Corticosteroids in Idiopathic Granulomatous Mastitis: A Systematic Review
by: Asel Wijesinghe, et al.
Published: (2024-10-01) -
Comparative Study between Intrapolyp Corticosteroid Injection and Oral Corticosteroid in Treatment of Allergic Nasal Polyposis
by: Nehad Hassan Abdelrahman, et al.
Published: (2023-07-01) -
Efficacy of Topical Administration of Corticosteroids for the Management of Dry Eye Disease: Systematic Review and Meta-Analysis
by: Julia Prinz, et al.
Published: (2022-11-01)